ESC Premium Access

NOAC Dosing, Adherence and Treatment Effects

Event: ESC CONGRESS 2020 - The Digital Experience
Topic: Oral Anticoagulation
Session type: Best ePosters
Date: 31 August 2020
Time: 08:30 - 08:30

Congress Session

6 presentations in this session

The effect of computer decision support on optimizing appropriate dosing of novel oral anticoagulant therapy in the IMPACT-AF study

Speaker: Doctor J. Cox (Halifax, CA)
Thumbnail

Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomised clinical trial

Speaker: Doctor A. Tzikas (Thessaloniki, GR)
Thumbnail

Real-world adherence to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation measured by an electronic medication event monitoring system

Speaker: Doctor M. Delesie (Edegem, BE)
Thumbnail

Naxos study: risk of bleeding with oral anticoagulants in non-valvular atrial fibrillation patients in France

Speaker: Professor N. Danchin (Paris, FR)
Thumbnail

Comparison between non-vitamin K antagonist oral anticoagulants versus warfarin for the risk of dementia in Asian patients with non-valvular atrial fibrillation

Speaker: Doctor S. Lee (Seoul, KR)
Thumbnail

Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry

Speaker: Doctor J. Gumprecht (Zabrze, PL)
Thumbnail

6 speakers from this session

Doctor Jafna Cox

Dalhousie University, Halifax (Canada)
6 presentations
0 follower

Doctor Apostolos Tzikas

Interbalkan Medical Center, Thessaloniki (Greece)
4 presentations
0 follower

Doctor Michiel Delesie

University of Antwerp, Edegem (Belgium)
0 follower

Professor Nicolas Danchin

European Hospital Georges Pompidou, Paris (France)
13 presentations
0 follower

Doctor So-Ryoung Lee

Seoul National University Hospital, Seoul (Korea (Republic of))
0 follower

Doctor Jakub Gumprecht

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)
0 follower

This platform is supported by

logo Novo Nordisk